Get complete Patent Opposition Report for Medichem

Comprehensive Analysis, Strategic Insights & Expert Evaluation – Stay Ahead in Your Patent Challenge.

Download Your Report Now

Explore patent oppositions filed by Medichem against competitors, revealing strategic technology disputes and market positioning. Monitor opposition details, timelines, and disputed innovations to understand competitive dynamics and IP enforcement strategy.

Patent NumberTitleApplicantOpposition Date
EP3251660Apixaban FormulationsBRISTOL MYERS SQUIBB IRELANDJul 14, 2020
EP3257500Apixaban FormulationsBRISTOL MYERS SQUIBB IRELANDJul 14, 2020
EP2099453Combination Therapy Of Substituted OxazolidinonesBAYERJun 5, 2018

Explore Medichem's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Patent NumberGrant DateTitleTotal Oppositions
EP2499914Dec 20, 2017Antiseptic Solutions Comprising Chlorhexidine Or Its Salt And An Anionic Dye And Their Preparation1